El papel de los probióticos en la prevención de las infecciones urinarias recurrentes en mujeres

  1. Jiménez Pacheco, Antonio
  2. Jiménez Pacheco, Araceli
  3. Moral Domínguez, E. del
Revista:
Actualidad médica

ISSN: 0365-7965

Año de publicación: 2013

Tomo: 98

Número: 788

Páginas: 45-49

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Actualidad médica

Resumen

Introducción: Las infecciones urinarias (IU) figuran entre las enfermedades infecciosas más prevalentes. Los antibióticos empleados para el tratamiento y la prevención de recurrencias generan un coste sanitario importante y una alteración de la microbiota vaginal, lo que ha llevado a buscar otras alternativas terapéuticas, entra ellas los probióticos. El objetivo del estudio es analizar el papel de los probióticos en la prevención de IU recurrentes en mujeres. Material y métodos: Realizamos una búsqueda en la base de datos PUBMED, de los artículos publicados hasta enero del 2013, con los términos �probiotics and urinary tract infection�, obteniendo 66 artículos de los cuales finalmente seleccionamos 37 artículos. Resultados: De los 37 artículos, 25 son revisiones bibliográficas, 6 ensayos clínicos randomizados, controlados y el resto estudios piloto y de casos-controles prospectivos. Se ha comparado la administración de Lactobacillus frente a trimetropin-sulfametoxazol (TMP / SMX) observando que Lactobacillus no cumple con los criterios de no inferioridad en la prevención de las IU en comparación con TMP / SMX. Asimismo, se comparó el consumo de zumo de arándano frente a Lactobacillus, observando una disminución del número de recurrencias en el grupo que tomó arándano. En los estudio es los que se comparó Lactobacillus frente a placebo si se ha observado un reducción entre el 50-70% en el número de recurrencias respecto al placebo. Conclusiones: Aunque la mayoría de los estudios son heterogéneos y de un tamaño muestral pequeño, el uso de ciertas cepas de Lactobacillus para la prevención recurrencias de ITU es prometedor.

Referencias bibliográficas

  • Abad CL, Safdar N. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections—a systematic review. J Chemother. 2009; 21:243-52.
  • Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care. 1994; 12:239-43.
  • Barbés C, Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS. 1999; 13:747-51.
  • Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther. 2008; 30:453-68.
  • Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012; 172:704-12.
  • Borchert D, Sheridan L, Papatsoris A, Faruquz Z, Barua JM, Junaid I, et al. Prevention and treatment of urinary tract infection with probiotics: Review and research perspective. Indian J Urol. 2008; 24:139-44.
  • Bruce AW, Reid G. Bruce AW, Reid G. Probiotics and the urologist. Can J Urol. 2003; 10:1785-9.
  • Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol. 2009; 60 Suppl 6:13-8.
  • Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J. 2003; 5(11):767-9.
  • Coppens P, Fernandes da Silva M, Pettman S. European regulations on nutroceuticals, dietary supplements and functional foods: A framework based on safety. Toxicology 2006; 221: 59-74.
  • Elmer GW. Probiotics: “living drugs”. Am J Health Syst Pharm. 2001; 58:1101-9.
  • Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs. 2006; 66:1253-61.
  • Foxman B, Barlow R; D´Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated cost. Ann Epidemiol 2000; 10: 509-15.
  • Hoesl CE, Altwein JE. The Probiotic Approach: An Alternative Treatment Option in Urology. Eur Urol 2005; 47: 288-96.
  • Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001; 17:259-68.
  • Juárez Tomás MS, Saralegui Duhart CI, De Gregorio PR, Vera Pingitore E, Nader-Macías ME. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates. Eur J Obstet Gynecol Reprod Biol. 2011; 159:399-406.
  • Kontiokari T, Laitinen J, Järvi L, Pokka T, Sundqvist K, Uhari M. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr. 2003; 77:600-4.
  • Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001; 322:1571.
  • Martín R, Soberón N, Vázquez F, Suárez JE. Vaginal microbiota: composition, protective role, associated pathologies, and therapeutic perspectives. Enferm Infecc Microbiol Clin. 2008; 26:160-7.
  • McMillan A, Dell M, Zellar MP, Cribby S, Martz S, Hong E, et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011; 86:58-64.
  • Miller JL, Krieger JN. Urinary tract infections cranberry juice, underwear, and probiotics in the 21st century. Urol Clin North Am. 2002; 29:695-9.
  • Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistanse. Mayo Clin Proc 2004; 79; 1048-54.
  • Nosseir SB, Lind LR, Winkler HA. Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health (Larchmt) 2012; 21:347-54.
  • Parkes GC. An overview of probiotics and prebiotics. Nurs Stand. 2007; 21:43-7.
  • Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001; 30:49-52.
  • Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev. 1990; 3:335-44.
  • Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther. 1992; 14:11-6.
  • Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther. 1995; 23: 32–45.
  • Reid G, Bruce AW. Could probiotics be an option for treating and preventing urogenital infections?. Medscape Womens Health. 2001; 6:9.
  • Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol. 2006; 24:28-32.
  • Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 2011; 183: 77-80.
  • Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003; 79:428-32.
  • Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. MedGenMed. 2004; 6:49.
  • Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 2002; 4:319-24.
  • Reid G, Dols J, Miller W. Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care. 2009; 12:583-7.
  • Reid G. Potential preventive strategies and therapies in urinary tract infection. World J Urol. 1999; 17:359-63.
  • Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr. 2001; 73:437S-443S.
  • Reid G. Probiotic Therapy and Functional Foods for Prevention of Urinary Tract Infections: State of the Art and Science. Curr Infect Dis Rep. 2000; 2:518-522.
  • Reid G. Probiotics for urogenital health. Nutr Clin Care. 2002; 5:3-8.
  • Reid G. The role of cranberry and probiotics in intestinal and urogenital tract health. Crit Rev Food Sci Nutr. 2002; 42:293-300.
  • Schneeberger C, Geerlings SE, Middleton P, Crowther CA. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev. 2012; 11:CD009279.
  • Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011; 52:1212-7.
  • Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents. 2006; 28 Suppl 1:S30-4
  • Waigankar SS, Patel V. Role of probiotics in urogenital healthcare. J Midlife Health. 2011; 2 5-10.
Fuente de los datos: Dialnet